New Insight into the Role of Reactive Oxygen Species (ROS) in Cellular Signal-Transduction Processes

International Review of Cell and Molecular Biology

Volumn 319, Issue , 2015, Pages 221-254

  Russell, Eileen G ^a   Cotter, Thomas G ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Cell survival; Redox; ROS; Signal transduction

Indexed keywords

ALLOPURINOL; ALPHA TOCOPHEROL; ANTIOXIDANT; APOCYNIN; ASCORBIC ACID; ATM PROTEIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DEPENDENT PROTEIN KINASE; DIPHENYLIODONIUM SALT; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR; FORKHEAD BOXO TRANSCRIPTION FACTOR; FORKHEAD TRANSCRIPTION FACTOR; I KAPPA B KINASE; INSULIN RECEPTOR KINASE; MITOGEN ACTIVATED PROTEIN KINASE; NOX INHIBITOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN KINASE B; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE; REACTIVE OXYGEN METABOLITE; SCAVENGER; THIOCTIC ACID; TRANSCRIPTION FACTOR NRF2; TRIAZOLOPYRIMIDINE DERIVATIVE; UBIDECARENONE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULOTROPIN RECEPTOR;

AGING; ANALYTIC METHOD; ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; BIOSYNTHESIS; DEGENERATIVE DISEASE; HUMAN; HYPERTENSION; INFLAMMATION; INTRACELLULAR SIGNALING; NEOPLASM; NERVOUS SYSTEM INFLAMMATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PREECLAMPSIA; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; ANIMAL; DRUG EFFECTS; METABOLISM; PHYSIOLOGY;

ANIMALS; ANTIOXIDANTS; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEIN TYROSINE PHOSPHATASES; PROTEIN-TYROSINE KINASES; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84938280119     PISSN: 19376448     EISSN: None     Source Type: Book Series    
DOI: 10.1016/bs.ircmb.2015.07.004     Document Type: Article

References (140)

1. Abe E., Matsubara K., Ochi H., Ito M., Oka K., Kameda K. Elevated levels of adhesion molecules derived from leukocytes and endothelial cells in patients with pregnancy-induced hypertension. Hypertens. Pregnancy 2003, 22:31-43.
2. Abid M.R., Spokes K.C., Shih S.C., Aird W.C. NADPH oxidase activity selectively modulates vascular endothelial growth factor signaling pathways. J. Biol. Chem. 2007, 282:35373-35385.
3. Anastasiou D., Poulogiannis G., Asara J.M., Boxer M.B., Jiang J.K., Shen M., Bellinger G., Sasaki A.T., Locasale J.W., Auld D.S., Thomas C.J., Vander Heiden M.G., Cantley L.C. Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses. Science 2011, 334:1278-1283.
4. Avruch J. Insulin signal transduction through protein kinase cascades. Mol. Cell Biochem. 1998, 182:31-48.
5. Baba H., Sueyoshi N., Shigeri Y., Ishida A., Kameshita I. Regulation of Ca(2+)/calmodulin-dependent protein kinase phosphatase (CaMKP) by oxidation/reduction at Cys-359. Arch. Biochem. Biophys. 2012, 526:9-15.
6. Bae Y.S., Sung J.Y., Kim O.S., Kim Y.J., Hur K.C., Kazlauskas A., Rhee S.G. Platelet-derived growth factor-induced H(2)O(2) production requires the activation of phosphatidylinositol 3-kinase. J. Biol. Chem. 2000, 275:10527-10531.
7. Bakker S.J., IJzerman R.G., Teerlink T., Westerhoff H.V., Gans R.O., Heine R.J. Cytosolic triglycerides and oxidative stress in central obesity: the missing link between excessive atherosclerosis, endothelial dysfunction, and beta-cell failure?. Atherosclerosis 2000, 148:17-21.
8. Bartosz G. Reactive oxygen species: destroyers or messengers?. Biochem. Pharmacol. 2009, 77:1303-1315.
9. von Bernhardi R., Eugenín J. Alzheimer's disease: redox dysregulation as a common denominator for diverse pathogenic mechanisms. Antioxid. Redox Signal 2012, 16:974-1031.
10. Boggon T.J., Eck M.J. Structure and regulation of Src family kinases. Oncogene 2004, 23:7918-7927.
11. Bouayed J., Bohn T. Exogenous antioxidants - double-edged swords in cellular redox state: health beneficial effects at physiologic doses versus deleterious effects at high doses. Oxid. Med. Cell Longev. 2010, 3:228-237.
12. Boutros T., Chevet E., Metrakos P. Mitogen-activated protein (MAP) kinase/MAP kinase phosphatase regulation: roles in cell growth, death, and cancer. Pharmacol. Rev. 2008, 60:261-310.
13. Brandt R., Keston A.S. Synthesis of diacetyldichlorofluorescin: a stable reagent for fluorometric analysis. Anal. Biochem. 1965, 11:6-9.
14. Brown M.T., Cooper J.A. Regulation, substrates and functions of src. Biochim. Biophys. Acta 1996, 1287:121-149.
15. Burgoyne J.R., Madhani M., Cuello F., Charles R.L., Brennan J.P., Schröder E., Browning D.D., Eaton P. Cysteine redox sensor in PKGIa enables oxidant-induced activation. Science 2007, 317:1393-1397.
16. Chan S.H., Hsu K.S., Huang C.C., Wang L.L., Ou C.C., Chan J.Y. NADPH oxidase-derived superoxide anion mediates angiotensin II-induced pressor effect via activation of p38 mitogen-activated protein kinase in the rostral ventrolateral medulla. Circ. Res. 2005, 97:772-780.
17. Chappell L.C., Enye S., Seed P., Briley A.L., Poston L., Shennan A.H. Adverse perinatal outcomes and risk factors for preeclampsia in women with chronic hypertension: a prospective study. Hypertension 2008, 51:1002-1009.
18. Chen K., Vita J.A., Berk B.C., Keaney J.F. c-Jun N-terminal kinase activation by hydrogen peroxide in endothelial cells involves SRC-dependent epidermal growth factor receptor transactivation. J. Biol. Chem. 2001, 276:16045-16050.
19. Chen X., Zhong Z., Xu Z., Chen L., Wang Y. 2',7'-Dichlorodihydrofluorescein as a fluorescent probe for reactive oxygen species measurement: forty years of application and controversy. Free Radic. Res. 2010, 44:587-604.
20. Chiarugi P. The redox regulation of LMW-PTP during cell proliferation or growth inhibition. IUBMB Life 2001, 52:55-59.
21. Cho K.J., Seo J.M., Kim J.H. Bioactive lipoxygenase metabolites stimulation of NADPH oxidases and reactive oxygen species. Mol. Cells 2011, 32:1-5.
22. Chrissobolis S., Faraci F.M. The role of oxidative stress and NADPH oxidase in cerebrovascular disease. Trends Mol. Med. 2008, 14:495-502.
23. Ciccia A., Elledge S.J. The DNA damage response: making it safe to play with knives. Mol. Cell 2010, 40:179-204.
24. Colavitti R., Pani G., Bedogni B., Anzevino R., Borrello S., Waltenberger J., Galeotti T. Reactive oxygen species as downstream mediators of angiogenic signaling by vascular endothelial growth factor receptor-2/KDR. J. Biol. Chem. 2002, 277:3101-3108.
25. Coppack S.W. Pro-inflammatory cytokines and adipose tissue. Proc. Nutr. Soc. 2001, 60:349-356.
26. Corcoran A., Cotter T.G. Redox regulation of protein kinases. FEBS J. 2013, 280:1944-1965.
27. Dandona P., Mohanty P., Ghanim H., Aljada A., Browne R., Hamouda W., Prabhala A., Afzal A., Garg R. The suppressive effect of dietary restriction and weight loss in the obese on the generation of reactive oxygen species by leukocytes, lipid peroxidation, and protein carbonylation. J. Clin. Endocrinol. Metab. 2001, 86:355-362.
28. Drummond G.R., Selemidis S., Griendling K.K., Sobey C.G. Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat. Rev. Drug Discov. 2011, 10:453-471.
29. Dudek S.M., Garcia J.G. Cytoskeletal regulation of pulmonary vascular permeability. J. Appl. Physiol. (1985) 2001, 91:1487-1500.
30. Esposito F., Chirico G., Montesano Gesualdi N., Posadas I., Ammendola R., Russo T., Cirino G., Cimino F. Protein kinase B activation by reactive oxygen species is independent of tyrosine kinase receptor phosphorylation and requires SRC activity. J. Biol. Chem. 2003, 278:20828-20834.
31. Fang J., Iyer A.K., Seki T., Nakamura H., Greish K., Maeda H. SMA-copolymer conjugate of AHPP: a polymeric inhibitor of xanthine oxidase with potential antihypertensive effect. J. Control Release 2009, 135:211-217.
32. Fang J., Sawa T., Maeda H. Factors and mechanism of "EPR" effect and the enhanced antitumor effects of macromolecular drugs including SMANCS. Adv. Exp. Med. Biol. 2003, 519:29-49.
33. Farber E., Rubin H. Cellular adaptation in the origin and development of cancer. Cancer Res. 1991, 51:2751-2761.
34. Fenster C.P., Weinsier R.L., Darley-Usmar V.M., Patel R.P. Obesity, aerobic exercise, and vascular disease: the role of oxidant stress. Obes. Res. 2002, 10:964-968.
35. Finkel T. Signal transduction by reactive oxygen species. J. Cell Biol. 2011, 194:7-15.
36. Galli S., Antico Arciuch V.G., Poderoso C., Converso D.P., Zhou Q., Bal de Kier Joffé E., Cadenas E., Boczkowski J., Carreras M.C., Poderoso J.J. Tumor cell phenotype is sustained by selective MAPK oxidation in mitochondria. PLoS One 2008, 3:e2379.
37. Ghosh S., Karin M. Missing pieces in the NF-kappaB puzzle. Cell 2002, 109(Suppl.):S81-S96.
38. Giannoni E., Buricchi F., Raugei G., Ramponi G., Chiarugi P. Intracellular reactive oxygen species activate Src tyrosine kinase during cell adhesion and anchorage-dependent cell growth. Mol. Cell Biol. 2005, 25:6391-6403.
39. Gielis J.F., Lin J.Y., Wingler K., Van Schil P.E., Schmidt H.H., Moens A.L. Pathogenetic role of eNOS uncoupling in cardiopulmonary disorders. Free Radic. Biol. Med. 2011, 50:765-776.
40. Goncharov N.V., Avdonin P.V., Nadeev A.D., Zharkikh I.L., Jenkins R.O. Reactive oxygen species in pathogenesis of atherosclerosis. Curr. Pharm. Des. 2015, 21:1134-1146.
41. Goodsell D. cAMP-dependent protein kinase (PKA). Mol. Mon. 2015, 10.2210/rcsb_pdb/mom_2012_8.
42. 2+- and phospholipid-independent activation of protein kinase C by selective oxidative modification of the regulatory domain. Proc. Natl. Acad. Sci. U.S.A. 1989, 86:6758-6762.
43. Gottlieb R.A. Cytochrome P450: major player in reperfusion injury. Arch. Biochem. Biophys. 2003, 420:262-267.
44. Greene E.L., Houghton O., Collinsworth G., Garnovskaya M.N., Nagai T., Sajjad T., Bheemanathini V., Grewal J.S., Paul R.V., Raymond J.R. 5-HT(2A) receptors stimulate mitogen-activated protein kinase via H(2)O(2) generation in rat renal mesangial cells. Am. J. Physiol. Renal Physiol. 2000, 278:F650-F658.
45. Guo Z., Kozlov S., Lavin M.F., Person M.D., Paull T.T. ATM activation by oxidative stress. Science 2010, 330:517-521.
46. Halliwell B. Oxidative stress and neurodegeneration: where are we now?. J. Neurochem. 2006, 97:1634-1658.
47. Harman D. Aging: a theory based on free radical and radiation chemistry. J. Gerontol. 1956, 11:298-300.
48. Hay N. The Akt-mTOR tango and its relevance to cancer. Cancer Cell 2005, 8:179-183.
49. He B.J., Joiner M.L., Singh M.V., Luczak E.D., Swaminathan P.D., Koval O.M., Kutschke W., Allamargot C., Yang J., Guan X., Zimmerman K., Grumbach I.M., Weiss R.M., Spitz D.R., Sigmund C.D., Blankesteijn W.M., Heymans S., Mohler P.J., Anderson M.E. Oxidation of CaMKII determines the cardiotoxic effects of aldosterone. Nat. Med. 2011, 17:1610-1618.
50. Hebert-Chatelain E. Src kinases are important regulators of mitochondrial functions. Int. J. Biochem. Cell Biol. 2013, 45:90-98.
51. Heeneman S., Haendeler J., Saito Y., Ishida M., Berk B.C. Angiotensin II induces transactivation of two different populations of the platelet-derived growth factor beta receptor. Key role for the p66 adaptor protein Shc. J. Biol. Chem. 2000, 275:15926-15932.
52. Hink U., Li H., Mollnau H., Oelze M., Matheis E., Hartmann M., Skatchkov M., Thaiss F., Stahl R.A., Warnholtz A., Meinertz T., Griendling K., Harrison D.G., Forstermann U., Munzel T. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ. Res. 2001, 88:E14-E22.
53. Hirano R., Sasamoto W., Matsumoto A., Itakura H., Igarashi O., Kondo K. Antioxidant ability of various flavonoids against DPPH radicals and LDL oxidation. J. Nutr. Sci. Vitaminol. (Tokyo) 2001, 47:357-362.
54. Hirooka Y. Role of reactive oxygen species in brainstem in neural mechanisms of hypertension. Auton. Neurosci. 2008, 142:20-24.
55. Hofmann F., Bernhard D., Lukowski R., Weinmeister P. cGMP regulated protein kinases (cGK). Handb. Exp. Pharmacol. 2009, 137-162.
56. Holmström K.M., Finkel T. Cellular mechanisms and physiological consequences of redox-dependent signalling. Nat. Rev. Mol. Cell Biol. 2014, 15:411-421.
57. Houstis N., Rosen E.D., Lander E.S. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006, 440:944-948.
58. Hsieh H.L., Yang C.M. Role of redox signaling in neuroinflammation and neurodegenerative diseases. Biomed. Res. Int. 2013, 2013:484613.
59. Humphries K.M., Deal M.S., Taylor S.S. Enhanced dephosphorylation of cAMP-dependent protein kinase by oxidation and thiol modification. J. Biol. Chem. 2005, 280:2750-2758.
60. Hybertson B.M., Gao B., Bose S.K., McCord J.M. Oxidative stress in health and disease: the therapeutic potential of Nrf2 activation. Mol. Asp. Med. 2011, 32:234-246.
61. Jankov R.P., Kantores C., Pan J., Belik J. Contribution of xanthine oxidase-derived superoxide to chronic hypoxic pulmonary hypertension in neonatal rats. Am. J. Physiol. Lung Cell Mol. Physiol. 2008, 294:L233-L245.
62. 2-mediated oxidation and inactivation of phosphatases in growth factor signaling. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:7147-7152.
63. Kamata H., Honda S., Maeda S., Chang L., Hirata H., Karin M. Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 2005, 120:649-661.
64. Kawamori D., Kajimoto Y., Kaneto H., Umayahara Y., Fujitani Y., Miyatsuka T., Watada H., Leibiger I.B., Yamasaki Y., Hori M. Oxidative stress induces nucleo-cytoplasmic translocation of pancreatic transcription factor PDX-1 through activation of c-Jun NH(2)-terminal kinase. Diabetes 2003, 52:2896-2904.
65. Kemble D.J., Sun G. Direct and specific inactivation of protein tyrosine kinases in the Src and FGFR families by reversible cysteine oxidation. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:5070-5075.
66. Kido Y., Nakae J., Accili D. Clinical review 125: the insulin receptor and its cellular targets. J. Clin. Endocrinol. Metab. 2001, 86:972-979.
67. Konior A., Schramm A., Czesnikiewicz-Guzik M., Guzik T.J. NADPH oxidases in vascular pathology. Antioxid. Redox Signal 2014, 20:2794-2814.
68. Koo Y.E., Fan W., Hah H., Xu H., Orringer D., Ross B., Rehemtulla A., Philbert M.A., Kopelman R. Photonic explorers based on multifunctional nanoplatforms for biosensing and photodynamic therapy. Appl. Opt. 2007, 46:1924-1930.
69. Krinsky N.I. Carotenoids as antioxidants. Nutrition 2001, 17:815-817.
70. Kuroda J., Nakagawa K., Yamasaki T., Nakamura K., Takeya R., Kuribayashi F., Imajoh-Ohmi S., Igarashi K., Shibata Y., Sueishi K., Sumimoto H. The superoxide-producing NAD(P)H oxidase Nox4 in the nucleus of human vascular endothelial cells. Genes Cells 2005, 10:1139-1151.
71. Kwon J., Lee S.R., Yang K.S., Ahn Y., Kim Y.J., Stadtman E.R., Rhee S.G. Reversible oxidation and inactivation of the tumor suppressor PTEN in cells stimulated with peptide growth factors. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:16419-16424.
72. Lassègue B., Sorescu D., Szöcs K., Yin Q., Akers M., Zhang Y., Grant S.L., Lambeth J.D., Griendling K.K. Novel gp91(phox) homologues in vascular smooth muscle cells: nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ. Res. 2001, 88:888-894.
73. Li Q., Zhang Y., Marden J.J., Banfi B., Engelhardt J.F. Endosomal NADPH oxidase regulates c-Src activation following hypoxia/reoxygenation injury. Biochem. J. 2008, 411:531-541.
74. Lisman J., Schulman H., Cline H. The molecular basis of CaMKII function in synaptic and behavioural memory. Nat. Rev. Neurosci. 2002, 3:175-190.
75. Lornejad-Schäfer M.R., Schäfer C., Schöffl H., Frank J. Cytoprotective role of mitogen-activated protein kinase phosphatase-1 in light-damaged human retinal pigment epithelial cells. Photochem. Photobiol. 2009, 85:834-842.
76. Ludwig A., Sommer A., Uhlig S. Assessment of endothelial permeability and leukocyte transmigration in human endothelial cell monolayers. Methods Mol. Biol. 2011, 763:319-332.
77. Lund J., Hafstad A.D., Boardman N.T., Rossvoll L., Rolim N.P., Ahmed M.S., Florholmen G., Attramadal H., Wisløff U., Larsen T.S., Aasum E. Exercise training promotes cardioprotection through oxygen-sparing action in high-fat fed mice. Am. J. Physiol. Heart Circ. Physiol. 2015, 10.1152/ajpheart.00734.02014.
78. Magesh S., Chen Y., Hu L. Small molecule modulators of Keap1-Nrf2-ARE pathway as potential preventive and therapeutic agents. Med. Res. Rev. 2012, 32:687-726.
79. Mallozzi C., Di Stasi A.M., Minetti M. Activation of src tyrosine kinases by peroxynitrite. FEBS Lett. 1999, 456:201-206.
80. Maritim A.C., Sanders R.A., Watkins J.B. Diabetes, oxidative stress, and antioxidants: a review. J. Biochem. Mol. Toxicol. 2003, 17:24-38.
81. Martyn K.D., Frederick L.M., von Loehneysen K., Dinauer M.C., Knaus U.G. Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases. Cell Signal 2006, 18:69-82.
82. Matsubara K., Higaki T., Matsubara Y., Nawa A. Nitric oxide and reactive oxygen species in the pathogenesis of preeclampsia. Int. J. Mol. Sci. 2015, 16:4600-4614.
83. Matsuoka T.A., Zhao L., Artner I., Jarrett H.W., Friedman D., Means A., Stein R. Members of the large Maf transcription family regulate insulin gene transcription in islet beta cells. Mol. Cell Biol. 2003, 23:6049-6062.
84. McNally J.S., Davis M.E., Giddens D.P., Saha A., Hwang J., Dikalov S., Jo H., Harrison D.G. Role of xanthine oxidoreductase and NAD(P)H oxidase in endothelial superoxide production in response to oscillatory shear stress. Am. J. Physiol. Heart Circ. Physiol. 2003, 285:H2290-H2297.
85. Milkiewicz M., Roudier E., Doyle J.L., Trifonova A., Birot O., Haas T.L. Identification of a mechanism underlying regulation of the anti-angiogenic forkhead transcription factor FoxO1 in cultured endothelial cells and ischemic muscle. Am. J. Pathol. 2011, 178:935-944.
86. Mittal M., Siddiqui M.R., Tran K., Reddy S.P., Malik A.B. Reactive oxygen species in inflammation and tissue injury. Antioxid. Redox Signal 2014, 20:1126-1167.
87. Miyamoto Y., Akaike T., Yoshida M., Goto S., Horie H., Maeda H. Potentiation of nitric oxide-mediated vasorelaxation by xanthine oxidase inhibitors. Proc. Soc. Exp. Biol. Med. 1996, 211:366-373.
88. Mollnau H., Schulz E., Daiber A., Baldus S., Oelze M., August M., Wendt M., Walter U., Geiger C., Agrawal R., Kleschyov A.L., Meinertz T., Münzel T. Nebivolol prevents vascular NOS III uncoupling in experimental hyperlipidemia and inhibits NADPH oxidase activity in inflammatory cells. Arterioscler. Thromb. Vasc. Biol. 2003, 23:615-621.
89. Negi G., Kumar A., Joshi R.P., Sharma S.S. Oxidative stress and Nrf2 in the pathophysiology of diabetic neuropathy: old perspective with a new angle. Biochem. Biophys. Res. Commun. 2011, 408:1-5.
90. Nogueira V., Hay N. Molecular pathways: reactive oxygen species homeostasis in cancer cells and implications for cancer therapy. Clin. Cancer Res. 2013, 19:4309-4314.
91. Nordberg J., Arnér E.S. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic. Biol. Med. 2001, 31:1287-1312.
92. Nose K., Shibanuma M., Kikuchi K., Kageyama H., Sakiyama S., Kuroki T. Transcriptional activation of early-response genes by hydrogen peroxide in a mouse osteoblastic cell line. Eur. J. Biochem. 1991, 201:99-106.
93. Nunn A.V., Guy G.W., Bell J.D. Endocannabinoids, FOXO and the metabolic syndrome: redox, function and tipping point-the view from two systems. Immunobiology 2010, 215:617-628.
94. Ostergaard H., Henriksen A., Hansen F.G., Winther J.R. Shedding light on disulfide bond formation: engineering a redox switch in green fluorescent protein. EMBO J. 2001, 20:5853-5862.
95. Pamukcu B., Lip G.Y., Shantsila E. The nuclear factor-kappa B pathway in atherosclerosis: a potential therapeutic target for atherothrombotic vascular disease. Thromb. Res. 2011, 128:117-123.
96. Pantano C., Reynaert N.L., van der Vliet A., Janssen-Heininger Y.M. Redox-sensitive kinases of the nuclear factor-kappaB signaling pathway. Antioxid. Redox Signal 2006, 8:1791-1806.
97. Pendyala S., Usatyuk P.V., Gorshkova I.A., Garcia J.G., Natarajan V. Regulation of NADPH oxidase in vascular endothelium: the role of phospholipases, protein kinases, and cytoskeletal proteins. Antioxid. Redox Signal 2009, 11:841-860.
98. Podrez E.A., Abu-Soud H.M., Hazen S.L. Myeloperoxidase-generated oxidants and atherosclerosis. Free Radic. Biol. Med. 2000, 28:1717-1725.
99. Reynaert N.L., Ckless K., Korn S.H., Vos N., Guala A.S., Wouters E.F., van der Vliet A., Janssen-Heininger Y.M. Nitric oxide represses inhibitory kappaB kinase through S-nitrosylation. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:8945-8950.
100. Reynaert N.L., van der Vliet A., Guala A.S., McGovern T., Hristova M., Pantano C., Heintz N.H., Heim J., Ho Y.S., Matthews D.E., Wouters E.F., Janssen-Heininger Y.M. Dynamic redox control of NF-kappaB through glutaredoxin-regulated S-glutathionylation of inhibitory kappaB kinase beta. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:13086-13091.
101. Ristow M., Zarse K., Oberbach A., Klöting N., Birringer M., Kiehntopf M., Stumvoll M., Kahn C.R., Blüher M. Antioxidants prevent health-promoting effects of physical exercise in humans. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:8665-8670.
102. Roberts J.M., Taylor R.N., Musci T.J., Rodgers G.M., Hubel C.A., McLaughlin M.K. Preeclampsia: an endothelial cell disorder. Am. J. Obstet. Gynecol. 1989, 161:1200-1204.
103. Rochette L., Zeller M., Cottin Y., Vergely C. Diabetes, oxidative stress and therapeutic strategies. Biochim. Biophys. Acta 2014, 1840:2709-2729.
104. Roskoski R. Src protein-tyrosine kinase structure and regulation. Biochem. Biophys. Res. Commun. 2004, 324:1155-1164.
105. Roskoski R. Src kinase regulation by phosphorylation and dephosphorylation. Biochem. Biophys. Res. Commun. 2005, 331:1-14.
106. Ryan K.A., Smith M.F., Sanders M.K., Ernst P.B. Reactive oxygen and nitrogen species differentially regulate Toll-like receptor 4-mediated activation of NF-kappa B and interleukin-8 expression. Infect. Immun. 2004, 72:2123-2130.
107. Schlessinger J. Ligand-induced, receptor-mediated dimerization and activation of EGF receptor. Cell 2002, 110:669-672.
108. Schrader M., Fahimi H.D. Mammalian peroxisomes and reactive oxygen species. Histochem. Cell Biol. 2004, 122:383-393.
109. Shabb J.B. Physiological substrates of cAMP-dependent protein kinase. Chem. Rev. 2001, 101:2381-2411.
110. Shi Q., Gibson G.E. Oxidative stress and transcriptional regulation in Alzheimer disease. Alzheimer Dis. Assoc. Disord. 2007, 21:276-291.
111. Son Y., Cheong Y.K., Kim N.H., Chung H.T., Kang D.G., Pae H.O. Mitogen-activated protein kinases and reactive oxygen species: how can ROS activate MAPK pathways?. J. Signal Transduct. 2011, 2011:792639.
112. Storz P. Forkhead homeobox type O transcription factors in the responses to oxidative stress. Antioxid. Redox Signal 2011, 14:593-605.
113. Stuart J.A., Maddalena L.A., Merilovich M., Robb E.L. A midlife crisis for the mitochondrial free radical theory of aging. Longev. Heal. 2014, 3:4.
114. 2 for platelet-derived growth factor signal transduction. Science 1995, 270:296-299.
115. Sundaresan M., Yu Z.X., Ferrans V.J., Sulciner D.J., Gutkind J.S., Irani K., Goldschmidt-Clermont P.J., Finkel T. Regulation of reactive-oxygen-species generation in fibroblasts by Rac1. Biochem. J. 1996, 318(Pt 2):379-382.
116. Tang H., Hao Q., Rutherford S.A., Low B., Zhao Z.J. Inactivation of SRC family tyrosine kinases by reactive oxygen species in vivo. J. Biol. Chem. 2005, 280:23918-23925.
117. Thannickal V.J., Day R.M., Klinz S.G., Bastien M.C., Larios J.M., Fanburg B.L. Ras-dependent and -independent regulation of reactive oxygen species by mitogenic growth factors and TGF-beta1. FASEB J. 2000, 14:1741-1748.
118. Thum T., Borlak J. Mechanistic role of cytochrome P450 monooxygenases in oxidized low-density lipoprotein-induced vascular injury: therapy through LOX-1 receptor antagonism?. Circ. Res. 2004, 94:e1-13.
119. Tonks N.K. Protein tyrosine phosphatases: from genes, to function, to disease. Nat. Rev. Mol. Cell Biol. 2006, 7:833-846.
120. Toyokuni S., Okamoto K., Yodoi J., Hiai H. Persistent oxidative stress in cancer. FEBS Lett. 1995, 358:1-3.
121. Truong T.H., Carroll K.S. Redox regulation of epidermal growth factor receptor signaling through cysteine oxidation. Biochemistry 2012, 51:9954-9965.
122. Truong T.H., Carroll K.S. Redox regulation of protein kinases. Crit. Rev. Biochem. Mol. Biol. 2013, 48:332-356.
123. Tschudi M.R., Mesaros S., Lüscher T.F., Malinski T. Direct in situ measurement of nitric oxide in mesenteric resistance arteries. Increased decomposition by superoxide in hypertension. Hypertension 1996, 27:32-35.
124. Ushio-Fukai M., Alexander R.W., Akers M., Yin Q., Fujio Y., Walsh K., Griendling K.K. Reactive oxygen species mediate the activation of Akt/protein kinase B by angiotensin II in vascular smooth muscle cells. J. Biol. Chem. 1999, 274:22699-22704.
125. Van de Bittner G.C., Dubikovskaya E.A., Bertozzi C.R., Chang C.J. In vivo imaging of hydrogen peroxide production in a murine tumor model with a chemoselective bioluminescent reporter. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:21316-21321.
126. Van Gaal L.F., Vertommen J., De Leeuw I.H. The in vitro oxidizability of lipoprotein particles in obese and non-obese subjects. Atherosclerosis 1998, 137(Suppl.):S39-S44.
127. Vigneron A., Vousden K.H. p53, ROS and senescence in the control of aging. Aging (Albany NY) 2010, 2:471-474.
128. Vincent H.K., Powers S.K., Stewart D.J., Shanely R.A., Demirel H., Naito H. Obesity is associated with increased myocardial oxidative stress. Int. J. Obes. Relat. Metab. Disord. 1999, 23:67-74.
129. Visconti R., Grieco D. New insights on oxidative stress in cancer. Curr. Opin. Drug Discov. Devel. 2009, 12:240-245.
130. Wang X., McCullough K.D., Franke T.F., Holbrook N.J. Epidermal growth factor receptor-dependent Akt activation by oxidative stress enhances cell survival. J. Biol. Chem. 2000, 275:14624-14631.
131. Watson J.D. Type 2 diabetes as a redox disease. Lancet 2014, 383:841-843.
132. van Wetering S., van Buul J.D., Quik S., Mul F.P., Anthony E.C., ten Klooster J.P., Collard J.G., Hordijk P.L. Reactive oxygen species mediate Rac-induced loss of cell-cell adhesion in primary human endothelial cells. J. Cell Sci. 2002, 115:1837-1846.
133. Wind S., Beuerlein K., Eucker T., Müller H., Scheurer P., Armitage M.E., Ho H., Schmidt H.H., Wingler K. Comparative pharmacology of chemically distinct NADPH oxidase inhibitors. Br. J. Pharmacol. 2010, 161:885-898.
134. Winter-Vann A.M., Johnson G.L. Integrated activation of MAP3Ks balances cell fate in response to stress. J. Cell Biochem. 2007, 102:848-858.
135. Woolley J.F., Stanicka J., Cotter T.G. Recent advances in reactive oxygen species measurement in biological systems. Trends Biochem. Sci. 2013, 38:556-565.
136. Xu S., Chamseddine A.H., Carrell S., Miller F.J. Nox4 NADPH oxidase contributes to smooth muscle cell phenotypes associated with unstable atherosclerotic plaques. Redox Biol. 2014, 2:642-650.
137. Yamashita N., Hoshida S., Otsu K., Asahi M., Kuzuya T., Hori M. Exercise provides direct biphasic cardioprotection via manganese superoxide dismutase activation. J. Exp. Med. 1999, 189:1699-1706.
138. Yang H., Raizada M.K. Role of phosphatidylinositol 3-kinase in angiotensin II regulation of norepinephrine neuromodulation in brain neurons of the spontaneously hypertensive rat. J. Neurosci. 1999, 19:2413-2423.
139. Zimmerman M.C., Dunlay R.P., Lazartigues E., Zhang Y., Sharma R.V., Engelhardt J.F., Davisson R.L. Requirement for Rac1-dependent NADPH oxidase in the cardiovascular and dipsogenic actions of angiotensin II in the brain. Circ. Res. 2004, 95:532-539.
140. Zinovkin R.A., Romaschenko V.P., Galkin I.I., Zakharova V.V., Pletjushkina O.Y., Chernyak B.V., Popova E.N. Role of mitochondrial reactive oxygen species in age-related inflammatory activation of endothelium. Aging (Albany NY) 2014, 6:661-674.